Figure 2From: Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation Marker immunostaining in tumor and uninvolved liver. Sections were immunostained as described and comparison samples are shown of HCC and surrounding non-tumor liver from the same specimens for CD133, EpCAM, CD90 and CD44.Back to article page